FDA grants 510(k) clearance to CT imaging analysis solution for intracerebral hemorrhage

The FDA has granted 510(k) clearance to a South Korea-based specialized medical AI startup for its non-contrast CT imaging analysis solution to detect intracerebral hemorrhage.
According to a press release from Heuron Co. Ltd., the clearance marks the first FDA approval of an AI-based brain disorder analysis solution from Korea for computer-aided triage and notification devices.
Heuron ICH is designed to automatically screen and signal potential cases of intracranial hemorrhage by relying solely on non-contrast CT images. Its primary function is to swiftly discern emergency brain hemorrhages

The FDA has granted 510(k) clearance to a South Korea-based specialized medical AI startup for its non-contrast CT imaging analysis solution to detect intracerebral hemorrhage.
According to a press release from Heuron Co. Ltd., the clearance marks the first FDA approval of an AI-based brain disorder analysis solution from Korea for computer-aided triage and notification devices.
Heuron ICH is designed to automatically screen and signal potential cases of intracranial hemorrhage by relying solely on non-contrast CT images. Its primary function is to swiftly discern emergency brain hemorrhages